Cytopathologic characteristics of SMARCB1 (INI-1) deficient sinonasal carcinoma: A potential diagnostic pitfall

Derek B Allison1, Justin A Bishop1, Syed Z Ali1

  • 1Department of Pathology, The Johns Hopkins University School of Medicine, Baltimore, Maryland.

Insights

SMARCB1 (INI-1) deficient sinonasal carcinoma presents with non-specific features on fine needle aspiration cytology. This rare tumor, characterized by plasmacytoid cells, requires consideration in differential diagnoses for sinonasal tract lesions.

Area of Science:

  • Oncology
  • Cytopathology
  • Genetics

Background:

  • Head and neck tumors are diverse, with some poorly differentiated and difficult to classify.
  • A subset exhibits rhabdoid/plasmacytoid features and SMARCB1 (INI-1) gene inactivation.
  • SMARCB1 (INI-1) deficient sinonasal carcinoma is a recently described entity with limited case reports.

Observation:

  • Fine needle aspiration (FNA) cytology of a retropharyngeal lymph node revealed plasmacytoid cells.
  • The cells showed monomorphism, loose cohesion, occasional nucleoli, and mitotic figures.
  • A background of necrosis was present, with no overt squamous or glandular differentiation.

Findings:

  • Initial diagnosis was metastatic myoepithelial carcinoma based on FNA findings.
  • Retrospective analysis of surgical excision confirmed loss of SMARCB1 (INI-1) tumor suppressor gene expression via immunohistochemistry.
  • Cytomorphologic features of SMARCB1 (INI-1) deficient sinonasal carcinoma are nonspecific and mimic other regional tumors.

Implications:

  • SMARCB1 (INI-1) deficient sinonasal carcinoma should be included in the differential diagnosis for plasmacytoid tumors of the sinonasal tract.
  • Accurate cytopathologic diagnosis is crucial for appropriate patient management.
  • Further research is needed to define the specific cytopathologic criteria for this rare entity.